Table 3: eGFR, creatinine and potassium
levels before L-AMB treatment in attacks with and without nephrotoxicity and
duration of L-AMB treatment.
|
|
Attacks with nephrotoxicity (n=16) |
Attacks without nephrotoxicity (n=46) |
P |
|
eGFR (ml/min/1,73m2) |
305(263.30-337) |
187(160.50-225) |
<0.001 |
|
Creatinine (mg/dl) |
0.25(0.17-0.30) |
0.37(0.26-0.47) |
<0.01 |
|
Potassium (mmol/L) |
4.12±0.56 |
4.0±0.64 |
>0.05 |
|
Duration of L-AMB treatment (days) |
14(10-18) |
14(9-22) |
>0.05 |
eGFR:
Estimated glomerular filtration rate.